Scrip 100 positions Glenmark amongst the Top 100 biopharmaceutical companies ranked by Pharmaceutical Sales in 2023; while Generics Bulletin places it in the Top 50 ... mL (1 mg/mL) Multiple-Dose ...
Scrip 100 positions Glenmark amongst the Top 100 biopharmaceutical companies ranked by Pharmaceutical Sales in 2023; while Generics Bulletin places it in the Top 50 ... mL (200 mg/mL) Single-Dose ...
The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.
The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...
Harrow , a leading North American eyecare pharmaceutical company, announced the execution of a five-year strategic supply and development ("SSD") agreement for TRIESENCE® (triamcinolone acetonide ...
with an annual production capacity exceeding 50 million units. The initial container systems will include 0.5 mL, 1 mL long, and 1 mL short syringes, along with 2R vials, all in ready-to-fill formats.
Glenmark Pharmaceuticals acquires and launches Acetylcysteine Injection in the US market, strengthening its injectable portfolio for growth.
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback